RGNNF (Renergen) Debt-to-Revenue : 19.64 (As of Aug. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Renergen Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Renergen's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was $18.23 Mil. Renergen's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was $37.53 Mil. Renergen's annualized Revenue for the quarter that ended in Aug. 2024 was $2.84 Mil. Renergen's annualized Debt-to-Revenue for the quarter that ended in Aug. 2024 was 19.63.

Renergen Debt-to-Revenue Historical Data

The historical data trend for Renergen's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Debt-to-Revenue Chart

Renergen Annual Data

Trend

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Debt-to-Revenue

Get a 7-Day Free Trial

135.66

281.31

313.78

71.94

43.17

Renergen Semi-Annual Data
	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24
Debt-to-Revenue	Get a 7-Day Free Trial												356.98	39.85	26.29	120.34	19.64

Competitive Comparison of Renergen's Debt-to-Revenue

For the Oil & Gas E&P subindustry, Renergen's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renergen's Debt-to-Revenue Distribution in the Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Renergen's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Renergen's Debt-to-Revenue falls into.

Renergen Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Renergen's Debt-to-Revenue for the fiscal year that ended in Feb. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(25.729	+	39.979)	/	1.522
	=	43.17

Renergen's annualized Debt-to-Revenue for the quarter that ended in Aug. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(18.229	+	37.533)	/	2.84
	=	19.63

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Aug. 2024) Revenue data.

Renergen Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renergen's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Renergen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (OTCPK:RGNNF) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

REN:South Africa 9960:Germany RLT:Australia

Address

25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196

Website

https://www.renergen.co.za

Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines